Clinical Trial Detail

NCT ID NCT03009201
Title Ribociclib and Doxorubicin Hydrochloride in Treating Patients Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors OHSU Knight Cancer Institute
Indications

angiosarcoma

myxosarcoma

malignant peripheral nerve sheath tumor

liposarcoma

pleomorphic liposarcoma

leiomyosarcoma

epithelioid sarcoma

pleomorphic rhabdomyosarcoma

sarcoma

fibrosarcoma

synovial sarcoma

Therapies

Doxorubicin + Ribociclib

Age Groups: child senior adult

Additional content available in CKB BOOST